Antimicrobials: Macrolides and Lincosamides Flashcards
macrolides drugs (3)
erythromycin
clarithromycin
azithromycin
macrolide activity
good against gram positives and gram negative aerobes
which macrolide is the best for gram pos?
erythromycin
which macrolide is the worst for gram pos?
azithromycin
which macrolide is the best for gram negative?
azithromycin
which macrolide is the worst for gram negative?
erythromycin
main use for clarithromycin
h pylori
clarithromycin dosing is different from azithromycin, how?
it is dosed more frequently, typically 2x/day
macrolide and gram negative aerobes
no efficacy
macrolide are very useful in the setting of
pneumonia, especially the atypical pathogens of pneumonia
atypical pathogens of pneumonia
legionella pneumophila
mycoplasma pneumoniae
chlamoydophila pmneumoniae
macrolide have activity against these organisms
strep pneumo and other strep spp h influenzae m cat legionella pneumoniae mycoplasma pneumoniae chlamydophila pneumoniae chalmidia trachomatis ureaplasma urealyticum borrelia burgdorfei h pylori (clari, azith)
erythromycin drug:drug interactions due to
metabolism through the CYP450 enzyme system
macrolides for MAC
clarithromycin
azithromycin
MAC prophylaxis
large dose of azithromycin 1x a week
azithromycin t 1/2
5 days
azithromycin vs fluoroquinolones
activity against atypical organisms may be superior in azithromycin
macrolides + EKG changes
QTc prolongation
*watch other QTc prolonging drugs
azithromycin course of therapy
only 5 days, has PAE.
erythromycin
dose related adverse events
GI: abdominal cramps, nausea, vomiting, diarrhea
thrombophlebitis if given IV
choelstatic hepatitis in rare cases
clarithromycin and azithromycin side effects
GI: less than erythromycin
tinnitus and dizziness (dose related)
erythromycin distribution
poor penetration into many body tissues/fluids
clarithromycin/azithromycin distribution
penetrates well into tissues, particularly sputum and lungs. achieves high concentration in alveolar macrophages.
elimination of macrolides
excreted in bile, small amounts in urine
t 1/2 of erythro and clarithro
short half lives
azithromycin t 1/2
68 hours. long.
dose adjustment in macrolides
hepatic impairment
renal impairment
Lincosamides drug
clindamycin
MoA Clindamycin, a lincosamide
binds to 50S ribosomal subunit, decreases protein synthesis.
distribution of clindamycin, a lincosamide
concentrates in bone, bile, and most other tissues but does not penetrate well into the CSF.
lincosamides are bacteriocidal or static?
static
lincosamides are very against
staph & strep (mssa, mrsa, streptococcus) and b fragilis
head and neck flora/mouth flora/sometimes GI
lincosamides and gram neg aerobes
no activity
lincosamides and toxoplasmosis
good activity against it
bone penetration of lincosamides
excellent
when is lincosamide a go to drug?
when they’re on a staph/strep IV abx and there isn’t an easy conversion to a PO drug. clindamycin may be used in this instance.
t 1/2 lincosamides
short, 2.4 hours
multi times a day dosing
GI adverse events: lincosamidses, specifically clindamycin
GI intolerance/diarrhea/pseudomembranous colitis
liver function and lincosamides
can cause LFTs and hepatotoxicity
patient education for lincosamides
esophageal irritant
drink lots of water, no laying down
hematologic side effect of lincosamide
rare: neutropenia/thrombocytopenia
dose adjustment for lincosamides
not required for renal insufficiency
higher doses of lincosamides may lead to
dose limiting GI toxicity
lincosamide monitoring
C&S
CBC
RFT
bowel changes
pregnancy/lactation considerations for lincosamides
C
excreted into breast milk
pediatric considerations: lincosamides
diarrhea
geriatric consideration for lincosamides
diarrhea
renal impairment and lincosamides
no adjustment needed
hepatic impairment and lincosamides
consider dose adjusting in severe hepatic dysfunction
macrolides monitoring
C&S
CBC
RFT
LFT for long term use
Pregnancy/lactation considerations for macrolides
category B/C
excreted into breastmilk at low concs
pediatric considerations for macrolides
n/a
geriatric considerations for macrolides
renal insufficiency
renal impairment and macrolides
dose adjust for GFR <30
hepatic impairment and macrolides
LFTs may increase